Profile | GDS4284 / 207674_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 178.99 | 48 |
GSM687648 | Patient 402 control | 294.325 | 56 |
GSM687653 | Patient 403 control | 95.0768 | 35 |
GSM687658 | Patient 404 control | 439.072 | 62 |
GSM687663 | Patient 411 control | 427.341 | 61 |
GSM687668 | Patient 422 control | 205.603 | 49 |
GSM687673 | Patient 424 control | 506.832 | 63 |
GSM687678 | Patient 425 control | 499.601 | 63 |
GSM687683 | Patient 427 control | 481.495 | 62 |
GSM687688 | Patient 428 control | 205.148 | 49 |
GSM687695 | Patient 441 control | 2901.71 | 89 |
GSM687699 | Patient 443 control | 702.585 | 68 |
GSM687704 | Patient 444 control | 209.007 | 49 |
GSM687707 | Patient 448 control | 275.833 | 52 |
GSM687712 | Patient 449 control | 347.128 | 58 |
GSM687719 | Patient 450 control | 893.597 | 72 |
GSM687724 | Patient 451 control | 143.545 | 39 |
GSM687728 | Patient 452 control | 2119.17 | 85 |
GSM687646 | Patient 401 treated 24h | 74.1191 | 29 |
GSM687649 | Patient 402 treated 24h | 292.415 | 56 |
GSM687665 | Patient 411 treated 24h | 283.071 | 53 |
GSM687651 | Patient 402 treated 4 weeks | 306.789 | 55 |
GSM687667 | Patient 411 treated 4 weeks | 187.095 | 46 |
GSM687670 | Patient 422 treated 24h | 271.068 | 53 |
GSM687671 | Patient 422 treated 4 weeks | 356.939 | 58 |
GSM687654 | Patient 403 treated 24h | 135.942 | 43 |
GSM687675 | Patient 424 treated 24h | 833.875 | 71 |
GSM687685 | Patient 427 treated 24h | 596.667 | 66 |
GSM687656 | Patient 403 treated 4 weeks | 64.6217 | 29 |
GSM687677 | Patient 424 treated 4 weeks | 218.443 | 50 |
GSM687687 | Patient 427 treated 4 weeks | 282.501 | 55 |
GSM687692 | Patient 428 treated 4h | 329.859 | 57 |
GSM687716 | Patient 449 treated 4h | 71.4795 | 28 |
GSM687722 | Patient 450 treated 4h | 515.814 | 63 |
GSM687680 | Patient 425 treated 24h | 379.703 | 59 |
GSM687690 | Patient 428 treated 24h | 383.05 | 60 |
GSM687700 | Patient 443 treated 24h | 1750.25 | 82 |
GSM687705 | Patient 444 treated 24h | 704.153 | 69 |
GSM687714 | Patient 449 treated 24h | 575.441 | 66 |
GSM687721 | Patient 450 treated 24h | 2308.56 | 86 |
GSM687682 | Patient 425 treated 4 weeks | 359.071 | 59 |
GSM687694 | Patient 428 treated 4 weeks | 415.97 | 61 |
GSM687702 | Patient 443 treated 4 weeks | 296.491 | 53 |
GSM687718 | Patient 449 treated 4 weeks | 176.548 | 46 |
GSM687723 | Patient 450 treated 4 weeks | 432.457 | 61 |
GSM687661 | Patient 404 treated 4h | 554.337 | 65 |
GSM687710 | Patient 448 treated 4h | 198.707 | 48 |
GSM687726 | Patient 451 treated 4h | 191.945 | 44 |
GSM687730 | Patient 452 treated 4h | 200.708 | 33 |
GSM687660 | Patient 404 treated 24h | 8960.42 | 96 |
GSM687697 | Patient 441 treated 24h | 2842.05 | 89 |
GSM687709 | Patient 448 treated 24h | 382.589 | 59 |
GSM687725 | Patient 451 treated 24h | 426.205 | 60 |
GSM687729 | Patient 452 treated 24h | 6204.81 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 216.66 | 47 |
GSM687731 | Patient 452 treated 4 weeks | 1045.14 | 74 |